| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 68105
The work described in this paper demonstrates that the cellular binding of transforming growth factor ß, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor is reduced as cell density is increased. The reduction in transforming growth factor ß binding was observed in five different cell lines. Examination of several of the cell lines, under conditions where transforming growth factor ß binding is reduced, revealed that epidermal growth factor binding, platelet-derived growth factor binding, and fibroblast growth factor binding are also reduced. In the case of NRK-49F cells, the reduction in transforming growth factor ß binding results from a decrease in the number of high-affinity receptors and not from a change in receptor affinity. Similarly, it was determined that the reduction in epidermal growth factor binding is due to a selective reduction in the high-affinity receptors for epidermal growth factor. Overall, the data suggest that the effect of cell density on growth factor binding, which we refer to as density-induced down regulation of growth factor receptors, differs both from down regulation induced by a specific growth factor and from receptor transmodulation.
1 Supported by grants from the Nebraska Department of Health (87-38), the National Institute of Child Health and Human Development (HD 19837), and the National Cancer Institute (Laboratory Cancer Research Center Support Grant CA 36727).
2 To whom requests for reprints should be addressed.
Received 12/18/87. Revised 4/ 6/88. Accepted 5/ 4/88.
This article has been cited by other articles:
![]() |
K. M. Kassel, P. R. Dodmane, N. A. Schulte, and M. L. Toews Lysophosphatidic Acid Induces Rapid and Sustained Decreases in Epidermal Growth Factor Receptor Binding via Different Signaling Pathways in BEAS-2B Airway Epithelial Cells J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 809 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kassel, N. A. Schulte, S. M. Parker, A. D. Lanik, and M. L. Toews Lysophosphatidic Acid Decreases Epidermal Growth Factor Receptor Binding in Airway Epithelial Cells J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 109 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Leotoing, M. Manin, D. Monte, S. Baron, Y. Communal, C. Lours, G. Veyssiere, L. Morel, and C. Beaudoin Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation J. Mol. Endocrinol., August 1, 2007; 39(2): 151 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.E. van Beurden, J.W. Von den Hoff, R. Torensma, J.C. Maltha, and A.M. Kuijpers-Jagtman Myofibroblasts in Palatal Wound Healing: Prospects for the Reduction of Wound Contraction after Cleft Palate Repair J. Dent. Res., October 1, 2005; 84(10): 871 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hutley, W. Shurety, F. Newell, R. McGeary, N. Pelton, J. Grant, A. Herington, D. Cameron, J. Whitehead, and J. Prins Fibroblast Growth Factor 1: A Key Regulator of Human Adipogenesis Diabetes, December 1, 2004; 53(12): 3097 - 3106. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Ediger, B. L. Danforth, and M. L. Toews Lysophosphatidic acid upregulates the epidermal growth factor receptor in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L91 - L98. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Stephen, L. E. Shaw, C. Larsen, D. Corcoran, and P. D. Darbre Insulin-like Growth Factor Receptor Levels Are Regulated by Cell Density and by Long Term Estrogen Deprivation in MCF7 Human Breast Cancer Cells J. Biol. Chem., October 19, 2001; 276(43): 40080 - 40086. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Petridou, O. Maltseva, S. Spanakis, and S. K. Masur TGF-{beta} Receptor Expression and Smad2 Localization Are Cell Density Dependent in Fibroblasts Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 89 - 95. [Abstract] [Full Text] |
||||
![]() |
G. Wu, R. S. Fan, W. Li, V. Srinivas, and M. G. Brattain Regulation of Transforming Growth Factor-beta Type II Receptor Expression in Human Breast Cancer MCF-7 Cells by Vitamin D3 and Its Analogues J. Biol. Chem., March 27, 1998; 273(13): 7749 - 7756. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Estival, V. Monzat, K. Miquel, F.ço. Gaubert, E. Hollande, M. Korc, N. Vaysse, and F.ço. Clemente Differential Regulation of Fibroblast Growth Factor (FGF) Receptor-1 mRNA and Protein by Two Molecular Forms of Basic FGF J. Biol. Chem., March 8, 1996; 271(10): 5663 - 5670. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |